Bang‐Yan Zhang

Bang‐Yan Zhang

Auto-generated profile, based on publicly available information

Bang‐Yan Zhang

Department of Otorhinolaryngology–Head and Neck Surgery Fu Jen Catholic University Hospital New Taipei City Taiwan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
BZBang‐Yan Zhang
Bang‐Yan Zhang
YWYu‐Chien Wang
Yu‐Chien Wang
KCKai-Chieh Chan
Kai-Chieh Chan
Objective: Sudden sensorineural hearing loss (SSNHL) is one of the few emergent otologic conditions. Although more than half of all patients would benefit from timely treatment, recurrence occasionally develops unexpectedly. The aim of our study is to evaluate the recurrence rate after SSNHL, and present the prognosis after first‐episode and recurrent SSNHL.Methods: A literature search was conducted of the PubMed and Embase electronic databases.Results: Seven studies with a total of 3781 patients were included, and 96 patients experienced recurrence. The recurrence rate ranged between 1.4% and 17%. The average time to recurrence was about 2 years in most studies. The majority of the studies reported using systemic steroids for treating first‐episode SSNHL, and one study used a plasma expander in patients with recurrent SSNHL. The recovery rate for first‐episode patients was 58%–79%, while that for recurrent SSNHL ranged widely, from 21% to 86%. There were no common risk factors for SSNHL recurrence among the studies, although low‐frequency hearing loss, the presence of tinnitus during follow‐up, and an increased neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio have been proposed.Conclusion: Understanding the recurrence rate, risk factors, and prognosis after recurrence of SSHNL is crucial for comprehensive medical care; in this respect, further prospective studies with long‐term follow‐up may be instructive.Level of Evidence: 4


3 October 2025 in American Journal of Otolaryngology
Verified
Journal Article
Open access
BZBang-Yan Zhang
Bang-Yan Zhang
Chen-Chi WuChen-Chi Wu
Chen-Chi Wu
TLTien-Chen Liu
Tien-Chen Liu
TYTing-Hua Yang
Ting-Hua Yang
To clarify the clinical characteristics, management, and prognosis of nontuberculous mycobacteria (NTM) otomastoiditis, a rare and intractable disease with high relapse risk. This study presents the largest case series to date, analyzing 30 patients with NTM otomastoiditis. This retrospective case series was conducted at a single tertiary referral center. Clinical data including causative pathogens, imaging findings, antibiotic regimens, surgical interventions, complications, and audiometric outcomes were reviewed and analyzed. Among the 30 patients (14 males; mean age 55 ± 20 years), Mycobacterium abscessus was identified in 26 (87 %) cases. Skull base osteomyelitis or intracranial involvement was present in 7 (23 %) patients. All patients received anti-NTM antibiotics, with macrolides being the most frequently prescribed. The median antibiotic duration was 13 months. Twenty-three (77 %) patients underwent surgery, and 12 (40 %) had additional operations. Among 23 patients with complete audiometric data, mean air-conduction hearing thresholds improved from 64.1 to 55.6 dB HL (p = 0.04); however, irreversible total deafness developed in 3 patients. Nontuberculous mycobacterial otomastoiditis requires early recognition and comprehensive management. Combined surgical debridement and prolonged antibiotic therapy are often necessary, and all patients can achieve disease control. Hearing outcomes vary, but functional preservation is possible in appropriately managed cases.

22 March 2026 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
CYChia‐Chi Yeh
Chia‐Chi Yeh
TYTing‐Chia Young
Ting‐Chia Young
BZBang‐Yan Zhang
Bang‐Yan Zhang
KCKai-Chieh Chan
Kai-Chieh Chan